Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 2116 Show results per page	View Search Criteria \| Help With Results

Last Modified: 3/28/2007 First Published: 10/1/2002


1.		Phase IV Randomized Study of Epoetin beta for Anemia Management in Patients With Stage IIB, III, or IVA Cervical Cancer Treated With Cisplatin and Radiotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care, Treatment				Completed				Over 18				Pharmaceutical / Industry				AGOSG-OVAR-MO16375-MARCH EU-20217, ROCHE-MO16375, ROCHE-RO2053859, NCT00046969

Last Modified: 2/1/1995


2.		Phase II/III Randomized Study of CDDP/5-FU vs CDDP/5-FU/IFN-A for Metastatic Pancreatic Cancer (Summary Last Modified 02/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				under 75								EORTC-40924

Last Modified: 8/13/2007


3.		Phase III Randomized Study of Accelerated Fractionation Radiotherapy vs Alternating Radiotherapy and CDDP/5-FU for Unresectable Head and Neck Cancer and Phase II Study of Synchronous Radiotherapy and CDDP/5-FU for Recurrent Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 to 75								CNR-011109 EU-95015

Last Modified: 6/1/1997


4.		Phase II-III Chemotherapy with CAP (CTX/ADR/CACP) vs AMSA for Advanced Transitional Cell Cancer of the Urinary Bladder (Summary Last Modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				SWOG-7922

Last Modified: 5/23/2007


5.		Phase II/III Chemotherapy with MVP (MITO/VBL/CACP) vs CHIP vs CBDCA vs VBL/CACP vs MVP-CAMP (MITO/VBL/CACP/CTX/ADR/MTX/PCB) in Patients with Metastatic (Stage III) non-Small Cell Bronchogenic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				EST-1583


6.		Phase II/III cis-Platinum in 2-Drug and 3-Drug Combinations with VP-16 and DAVA for Advanced non-Oat Cell Carcinoma of the Lung

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								MDA-DT-8075 NCI-D81-043-098


7.		Phase II/III CAP (CTX/ADR/CACP) Chemotherapy with or without Radiotherapy for Inoperable non-Small Cell Lung Cancer Comparing Weekly Intravenous ADR vs a 24-Hour Infusion Every 3 Weeks

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								MDA-DT-8102


8.		Master Protocol to Compare MTX/5-FU vs CACP/5-FU vs Phase II Agent for Squamous Cell Cancer of the Head and Neck (Summary last modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				SWOG-8223/24/25 SWOG-8224, SWOG-8225

Last Modified: 4/12/2006


9.		Phase II/III Chemotherapy with FAP (5-FU/ADR/CACP) vs FAT (5-FU/ADR/TZT) vs FAMe (5-FU/ADR/MeCCNU) in Metastatic or Unexplored Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								GITSG-8380


10.		Phase II/III Chemotherapy with MTX vs MTX/CACP for Patients with Regionally Advanced or Metastatic Carcinoma of the Urinary Bladder

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								NBCG-14

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute